DEA moves to ban opioid-like kratom compound 7-OH
The move follows 165 poison-control cases and would subject sales above a set threshold to heroin-like penalties, officials said.
- On Wednesday, the U.S. Drug Enforcement Administration filed an intent to temporarily place 7-OH and three related substances—MP, MGM-15, and MGM-16—into Schedule I of the Controlled Substances Act.
- The DEA cited 165 poison control exposure cases involving 7-OH from January through July 2025, with 35% resulting in serious health problems; HHS Secretary Robert F. Kennedy Jr. warned these substances "fuel addiction and put American lives at risk."
- This temporary scheduling targets "highly concentrated, synthetic 7-OH products" rather than natural kratom leaf, a distinction the American Kratom Association supports to differentiate between botanical products and chemically manipulated opioids.
- Once finalized, the designation subjects anyone who manufactures, distributes, or sells these substances to federal criminal and administrative penalties similar to heroin or LSD, with the DEA able to issue a final order 30 days after publication.
- The AKA is urging state officials to adopt consumer protection laws banning chemically manipulated 7-OH derivatives while explicitly warning lawmakers not to use the crisis as an excuse to ban natural kratom leaf.
57 Articles
57 Articles
Of Course 7-OH and Cychlorphine Fit Schedule I Criteria. All New Drugs Do.
The Drug Enforcement Administration plans to order emergency placements of 7-OH, cychlorphine and multiple substances related to each in Schedule I of the Controlled Substances Act (CSA). The actions reflect the agency’s escalating use of emergency scheduling powers, and how in the aftermath of its class-wide fentanyl bans it’s not facing too much pressure to distinguish one synthetic opioid from another. On July 1 the DEA announced that it had …
DEA moves to ban opioid-like kratom compound 7-OH
The Drug Enforcement Administration (DEA) is planning to temporarily ban products containing certain synthetic versions of kratom, placing them in the same category as heroin and LSD. The agency on Wednesday said it plans to classify a psychoactive compound called 7-hydroxymitragynine (7-OH) and three related substances as Schedule I, meaning they have no accepted medical...
DEA Takes Steps to Ban 7-OH, a Risky Kratom Related Substance
Washington, D.C.-The government is moving to crack down on a chemical called 7-OH, which comes from the kratom plant used in natural pain relief marketed products, but can be made into a much stronger and riskier product. The Drug Enforcement Administration (DEA) announced two actions this week. Both are early steps toward making these substances illegal under the strictest drug category, called Schedule I. That’s the same category as drugs like…
Coverage Details
Bias Distribution
- 45% of the sources are Center
![[your]NEWS](/_next/image?url=https%3A%2F%2Fgroundnews.b-cdn.net%2Finterests%2Ffb6dc495f74049f513563c33352175eaa0ecd509.jpg%3Fwidth%3D60&w=128&q=75)
Factuality
To view factuality data please Upgrade to Premium
